Journal
PROTEOMICS CLINICAL APPLICATIONS
Volume 9, Issue 1-2, Pages 134-146Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.201400122
Keywords
CFTR mutation; Cystic fibrosis; Infection; Inflammation
Funding
- Macquarie University
- Australian Research Council [FS110200026]
- Biomolecular Frontiers Research Centre, Macquarie University
- Australian Research Council [FS110200026] Funding Source: Australian Research Council
Ask authors/readers for more resources
Cystic fibrosis (CF) is a congenital disease that results in great morbidity and mortality mainly in the Caucasian population. Although CF is a monogenic disease caused by mutation in the CF conductance transmembrane regulator (CFTR) gene, most of the related mortality can be attributed to infection mediated by opportunistic bacterial and fungal pathogens. Over the past decade, advancements in the field of proteomics have helped to gain insight into the repertoire of host and pathogen proteins involved in CF pathophysiology. This review provides an overview of the contributions of proteomic studies in advancing our knowledge of the biology of CF and disease progression associated with pathogen infection and host defense responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available